An evaluation of empagliflozin and it’s applicability to hypertension as a therapeutic option

Lakshini Y Herat,Vance B Matthews,Aaron L Magno,Marcio G Kiuchi,Revathy Carnagarin,Markus Schlaich; Lakshini Y Herat; Vance B Matthews; Aaron L Magno; Marcio G Kiuchi; Revathy Carnagarin; Markus Schlaich

An evaluation of empagliflozin and it’s applicability to hypertension as a therapeutic option

Lakshini Y Herat,Vance B Matthews,Aaron L Magno,Marcio G Kiuchi,Revathy Carnagarin,Markus Schlaich;Lakshini Y Herat;Vance B Matthews;Aaron L Magno;Marcio G Kiuchi;Revathy Carnagarin;Markus Schlaich;

expert opinion on pharmacotherapy 2020 Vol. 21 pp. 1157-1166

280

schlaich2020expertan

Keywords

hypertension Diabetes cardiovascular disease empagliflozin sglt2 sglt2 inhibitors

Access

DOI:

10.1080/14656566.2020.1751815

URL:

https://sciprofiles.com/publication/view/af977d36d...

Citation

ID: 111714

Ref Key: schlaich2020expertan

Use this key to autocite in SciMatic or Thesis Manager

References

No Bibliography

Blockchain Verification

Account:

NFT Contract Address:

0x95644003c57E6F55A65596E3D9Eac6813e3566dA

Article ID:

111714

Unique Identifier:

10.1080/14656566.2020.1751815

Network:

Scimatic Chain (ID: 481)

Blockchain Readiness Checklist

Authors

Abstract

Journal Name

Year

Title

4/5

Blockchain Upload Locked

Complete all 5 checklist items to tokenize your article

Gas fees required in SCI Coins

Buy SCI

Saymatik Web3.0 Wallet

Google Play

App Store

Coming soon

Reference Key: lastname+year+titlefirstword+journalfirstword

Article Type (Article, Book, Proceedings etc.)

Add a reference in a raw form. Our automatic system will correct it later.